JUB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.711600E-01
Normal-vs-Stage2
5.185200E-01
Normal-vs-Stage3
9.274000E-01
Normal-vs-Stage4
6.869800E-01
Stage1-vs-Stage2
3.970400E-01
Stage1-vs-Stage3
8.787400E-01
Stage1-vs-Stage4
6.364600E-01
Stage2-vs-Stage3
3.890000E-01
Stage2-vs-Stage4
9.109200E-01
Stage3-vs-Stage4
5.368800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.287400E-01
Normal-vs-AfricanAmerican
5.702600E-01
Normal-vs-Asian
8.673600E-01
Caucasian-vs-AfricanAmerican
9.235000E-01
Caucasian-vs-Asian
5.513400E-01
AfricanAmerican-vs-Asian
5.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.406000E-01
Normal-vs-Female
6.023000E-01
Male-vs-Female
9.758000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.526600E-01
Normal-vs-Age(41-60Yrs)
4.141400E-01
Normal-vs-Age(61-80Yrs)
7.416000E-01
Normal-vs-Age(81-100Yrs)
5.657400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.247600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.720800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.725600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.349650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.855600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.750800E-01
Normal-vs-Daily Drinker
6.353000E-01
Normal-vs-Weekly Drinker
6.375000E-01
Normal-vs-Occasional Drinker
5.272600E-01
Normal-vs-Social Drinker
2.546200E-01
Non Drinker-vs-Daily Drinker
3.244600E-01
Non Drinker-vs-Weekly Drinker
4.201600E-01
Non Drinker-vs-Occasional Drinker
2.766600E-01
Non Drinker-vs-Social Drinker
3.868400E-02
Daily Drinker-vs-Weekly Drinker
9.525400E-01
Daily Drinker-vs-Occasional Drinker
8.332800E-01
Daily Drinker-vs-Social Drinker
6.120000E-01
Weekly Drinker-vs-Occasional Drinker
8.983800E-01
Weekly Drinker-vs-Social Drinker
5.885600E-01
Occasional Drinker-vs-Social Drinker
3.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.611400E-01
Normal-vs-Grade 2
2.868400E-01
Normal-vs-Grade 3
1.643250E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.001710E-02
Grade 1-vs-Grade 3
1.165450E-04
Grade 1-vs-Grade 4
7.611400E-01
Grade 2-vs-Grade 3
7.178600E-03
Grade 2-vs-Grade 4
2.868400E-01
Grade 3-vs-Grade 4
1.643250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.860400E-01
Normal-vs-NonDiabetic
5.743800E-01
Diabetic-vs-NonDiabetic
4.279800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.837200E-01
Normal-vs-NoPancreatitis
6.109800E-01
Pancreatitis-vs-NoPancreatitis
9.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.393600E-01
Normal-vs-N1
5.014600E-01
N0-vs-N1
1.209520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.458640E-01
Normal-vs-TP53-NonMutant
9.006400E-01
TP53-Mutant-vs-TP53-NonMutant
1.73329999997307E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
